Pharvaris (PHVS) Interest Coverage Ratio (2020 - 2024)

Pharvaris (PHVS) posted Interest Coverage Ratio of 0.0 for Q3 2024, down 99.97% on a QoQ basis from 1.0 in Q4 2023.

Pharvaris (PHVS) Interest Coverage Ratio (2020 - 2024) Analysis & Trends

Pharvaris' Interest Coverage Ratio history runs 5 years deep, the most recent figure standing at 0.0 for Q3 2024.

Quarterly Interest Coverage Ratio changed N/A year-over-year to 0.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was 2.0 (down 100.0% YoY) and the FY2023 annual result came in at 0.0, up 100.0% from the prior year.
Interest Coverage Ratio was 0.0 for Q3 2024 at Pharvaris, down from 1.0 in the prior quarter.
Across five years, Interest Coverage Ratio topped out at 1149.68 in Q4 2022 and bottomed at 859637009.45 in Q3 2022.
A 5-year average of 71636419.0 and a median of 25.8 in 2021 frame the typical range for Interest Coverage Ratio.
Peak annual rise in Interest Coverage Ratio reached 184.09% in 2022, while the deepest fall reached 507762871.15% in 2022.
Pharvaris' Interest Coverage Ratio stood at 135.02 in 2020, then tumbled by 976.57% to 1453.56 in 2021, then jumped by 179.09% to 1149.68 in 2022, then slumped by 99.91% to 1.0 in 2023, then slumped by 99.97% to 0.0 in 2024.
Business Quant data shows PHVS's Interest Coverage Ratio at 0.0 in Q3 2024, 1.0 in Q4 2023, and 1149.68 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	658.42
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-157.58
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	7.60
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	2.71
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	22.72
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-0.38
10	Pharvaris	2.22 Bn	1.94 Bn	-	-

Download Data